Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Argus Health
Johnson and Johnson
Colorcon
Covington
Fuji
Federal Trade Commission
Harvard Business School
Citi

Generated: January 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Belimumab

« Back to Dashboard

US Patents for Belimumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Belimumab ➤ Try a Free Trial Compositions and methods for treating or preventing lupus The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) ➤ Try a Free Trial
Belimumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Belimumab ➤ Try a Free Trial Methods for diagnosing systemic lupus erythematosus Exagen Diagnostics, Inc. (Vista, CA) ➤ Try a Free Trial
Belimumab ➤ Try a Free Trial Pretreatment of a biological sample from an autoimmune disease subject Genentech, Inc. (South San Francisco, CA) ➤ Try a Free Trial
Belimumab ➤ Try a Free Trial Stabilizing alkylglycoside compositions and methods thereof Aegis Therapeutics LLC (San Diego, CA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Belimumab

Drugname Country Document Number Estimated Expiration Related US Patent
Belimumab Australia 2010364324 2030-11-24 ➤ Try a Free Trial
Belimumab Canada 2818712 2030-11-24 ➤ Try a Free Trial
Belimumab Japan 2014505020 2030-11-24 ➤ Try a Free Trial
Belimumab Japan 5850943 2030-11-24 ➤ Try a Free Trial
Belimumab South Korea 101813482 2030-11-24 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cerilliant
AstraZeneca
US Department of Justice
Moodys
Federal Trade Commission
Daiichi Sankyo
Julphar
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.